NY bill would rollback COVID-19 liability protection for hospitals, nursing homes
ALBANY — Democratic state lawmakers are considering legislation this week that would partially rollback generous lawsuit liability protections for hospitals and nursing homes related to the coronavirus crisis, The Post has learned.
Legislative leaders in the state Senate and Assembly introduced a bill late Monday night that if passed, would remove immunity protections for healthcare...
Does Cuomo Share Blame for 6,200 Virus Deaths in N.Y. Nursing Homes?
U.S. Hospitals Lose Legal Challenge to Trump Price Transparency Rule
Bayer to pay up to $10.9 billion to settle bulk of Roundup weedkiller cancer lawsuits
Regeneron Funneled Kickbacks Through a Patient Charity, Federal Lawsuit Claims
The drugmaker Regeneron funneled tens of millions of dollars to a charity that paid the out-of-pocket costs for patients who took the company’s expensive eye drug, then lied to internal auditors about it, according to a lawsuit filed Wednesday by federal prosecutors in Massachusetts.
The suit, filed in the U.S. District Court of Massachusetts in...
Women With Cancer Awarded Billions in Baby Powder Suit
A Missouri appeals court on Tuesday ordered Johnson & Johnson and a subsidiary to pay $2.1 billion in damages to women who blamed their ovarian cancers on the company’s talcum products, including its iconic baby powder.
The decision slashed by more than half a record award of $4.69 billion in compensatory and punitive damages to...
FDA designates recall of abdominal stent graft system as class 1
As nursing home residents died, new covid-19 protections shielded companies from lawsuits. Families say that hides the truth.
One afternoon in early April, Brenda Anagnos crouched in the bushes outside a nursing home in Windsor, Conn., and pressed her face to the window.
“Mommy,” she yelled. “I’m here.”
From outside the locked-down facility, Anagnos said she watched her mother, wearing a red tank top, shiver beneath a hospital sheet. Diagnosed with covid-19, she could...
As expected, more diabetes medicine recalled because too much of a carcinogen was found
For the second time in a week, a maker of Type 2 diabetes drug Metformin announced a recall because the drug might have too much NDMA, a substance that can cause cancer in certain amounts.
The FDA said it found too much NDMA (N-Nitrosodimethylamine) in seven lots of Amneal’s Pharmaceuticals Metformin Hydrochloride Extended Release 500...
U.S. FDA asks five firms to recall diabetes drug with high levels of probable carcinogen
(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it has recommended five pharmaceutical firms to voluntarily recall their diabetes drug metformin after the agency found high levels of a possible cancer-causing impurity in some versions of the medication.
The agency said the drugs contained the probable carcinogen N-nitrosodimethylamine (NDMA) beyond acceptable...
